Dr. Hafiz Shoaib Sarwar

Assistant Professor

shoaib.sarwar@ucp.edu.pk

Profile Summary

Dr. Hafiz Shoaib Sarwar has 7 years of research experience in Pharmaceutics focused towards the targeted drug delivery via nanomedicine, targeting cancer and infectious diseases. Published 33 peer reviewed papers in high impact journals including one book chapter. Successfully supervised more than 15 M. Phil students and taught various courses at undergraduate level. A creative professional with excellent oral and written communication skills, adept at operating in a multi-functional and team-oriented work environment.

Qualification

PhD Pharmacy	Pharmaceutics	Quad-I-Azam University, Islamabad	2019
M.Phil.	Pharmaceutics	Bahauddin Zakariya University, Multan	2014
Pharm-D	Pharmacy	The Islamia University of Bahawalpur	2012

Experience

Assistant Professor	Faculty of Pharmacy, University of Central Punjab, Lahore	November 2021-till to date
Assistant Professor	Riphah Institute of Pharmaceutical Sciences, Riphah International University, Lahore Campus	October 2019-October 2021
Senior Lecturer	Riphah Institute of Pharmaceutical Sciences, Riphah International University, Lahore Campus	Feb 2019- September 2019
Lecturer	The University of Lahore Islamabad Campus	September 2015-Jan 2017

Publications

1	Enhanced solubility and biopharmaceutical performance of atorvastatin and metformin via electrospun polyvinylpyrrolidone-hyaluronic acid composite nanoparticles. Iqbal, R., Qureshi, O.S., Yousaf, A.M., Raza, S.A., Sarwar, H.S., Shahnaz, G., Saleem, U. and Sohail, M.F., 2021. European Journal of Pharmaceutical Sciences, 161, p.105817.
2	Fabrication and optimization of pH-sensitive mannose-anchored nano-vehicle as a promising approach for macrophage uptake. Mukhtar, M., Zesshan, M., Khan, S., Shahnaz, G., Khan, S.A., Sarwar, H.S., Pasha, R.A. and Ali,H., Applied Nanoscience, 10(11), pp.4013-4027
3	Oral delivery and enhanced efficacy of antimonal drug through macrophage-guided multifunctional nanocargoes against visceral Leishmaniasis. Sarwar, H.S., Varikuti, S., Sohail, M.F., Sarwar, M., Akhtar, S., Satoskar, A.R. and Shahnaz, G. European journal of pharmaceutics and biopharmaceutics, 152, pp.307-317.
4	Mannosylated thiolated paromomycin-loaded PLGA nanoparticles for the oral therapy of visceral leishmaniasis. Afzal, I., Sarwar, H.S., Sohail, M.F., Varikuti, S., Jahan, S., Akhtar, S., Yasinzai, M., Satoskar, A.R. and Shahnaz, G. Nanomedicine, 14(4), pp.387-406
5	Mannosylated thiolated polyethylenimine nanoparticles for the enhanced efficacy of antimonial drug against Leishmaniasis. Sarwar, H.S., Ashraf, S., Akhtar, S., Sohail, M.F., Hussain, S.Z., Rafay, M., Yasinzai, M., Hussain, I. and Shahnaz, G. Nanomedicine, 13(1), pp.25-41
6	Design of mannosylated oral amphotericin B nanoformulation: efficacy and safety in visceral leishmaniasis. Sarwar, H.S., Sohail, M.F., Saljoughian, N., Rehman, A.U., Akhtar, S., Nadhman, A., Yasinzai, M., Gendelman, H.E., Satoskar, A.R. and Shahnaz, G. Artificial cells, nanomedicine, and biotechnology, 46(sup1), pp.521-531.
7	Cell to rodent: toxicological profiling of folate grafted thiomer enveloped nanoliposomes. Sohail, M.F., Sarwar, H.S., Javed, I., Nadhman, A., Hussain, S.Z., Saeed, H., Raza, A., Irfan Bukhari, N., Hussain, I. and Shahnaz, G. Toxicology research, 6(6), pp.814-821
8	Redox biology of Leishmania and macrophage targeted nanoparticles for therapy. Sarwar, H.S., Akhtar, S., Sohail, M.F., Naveed, Z., Rafay, M., Nadhman, A., Yasinzai, M. And Shahnaz, G., Nanomedicine, 12(14), pp.1713-1725.
9	Redox biology of Leishmania and macrophage targeted nanoparticles for therapy. Sarwar, H.S., Akhtar, S., Sohail, M.F., Naveed, Z., Rafay, M., Nadhman, A., Yasinzai, M. And Shahnaz, G., Nanomedicine, 12(14), pp.1713-1725. Folate grafted thiolated chitosan enveloped nanoliposomes with enhanced oral bioavailability and anticancer activity of docetaxel. Sohail, M.F., Javed, I., Hussain, S.Z., Sarwar, S., Akhtar, S., Nadhman, A., Batool, S., Bukhari, N.I., Saleem, R.S.Z., Hussain, I. and Shahnaz, G. Journal of Materials Chemistry B, 4(37), pp.6240-6248.
10	Self-nanoemulsifying drug delivery system (SNEDDS) for improved oral bioavailability of chlorpromazine: in vitro and in vivo evaluation. Baloch, J., Sohail, M.F., Sarwar, H.S., Kiani, M.H., Khan, G.M., Jahan, S., Rafay, M., Chaudhry, M.T., Yasinzai, M. and Shahnaz, G., Medicina, 55(5), p.210.

Dr. Hafiz Shoaib Sarwar